Komen has reversed their decision.
Associated Press
NEW YORK—The Susan G. Komen for the Cure breast-cancer charity said it is reversing its decision to cut breast-screening grants to Planned Parenthood.
"We want to apologize to the American public for recent decisions that cast doubt upon our commitment to our mission of saving women's lives," a Komen statement said.
As reported by the Associated Press on Tuesday, Komen had adopted criteria excluding Planned Parenthood from grants because it was under government investigation, notably a probe launched in Congress at the urging of anti-abortion groups.
Komen said Friday it would change the criteria so it wouldn't apply to such investigations.
"We will continue to fund existing grants, including those of Planned Parenthood, and preserve their eligibility to apply for future grants," the statement said.
Surprise surprise.
ReplyDeleteTold you I didn't like them
That is sad news...I am surprised they have the nerve to reverse their decision, when it was so final and they had defended themselves because PP is under investigation! That was a totally logical, sound reason to publish! Cannot believe they caved to pressure and said they would basically loophole around the investigation status. I noticed, over the summer, that there are many other cancer awareness groups which are gaining prominence, to give to.
ReplyDeleteDanielle, it really doesn't make sense to me either. It really makes them seem wishy-washy. I too have noticed the other cancer groups and am glad there is an alternative.
ReplyDeleteSad that they gave in to the pressure. Unfortunately, the conservatives are the ones who keep quiet. There was an article in our local paper stating that the PPH in town doesn't receive funds from Komen.
ReplyDeleteThey gave in to the pressure - so sickening!
ReplyDeleteThey have also now "re-clarified" their position on ESCR. Blurgh.
ReplyDeletehttp://ww5.komen.org/uploadedFiles/Content/AboutUs/MediaCenter-2/StatementEmbryonicStemCell_252012.pdf
Did I mention I don't like them?